Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization (2023)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.42538
Publication URI: http://dx.doi.org/10.1002/art.42538
Type: Journal Article/Review
Parent Publication: Arthritis & Rheumatology
Issue: 10